Press release
July 28, 2026
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
Pulmonx Corp (LUNG)
REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Canaccord Genuity 46 th Annual Growth